Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Stock Crosses Above 50-Day Moving Average – Here’s Why

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) shares passed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $31.74 and traded as high as $32.37. Fidelity Disruptive Medicine ETF shares last traded at $32.0360, with a volume of 12,202 shares trading hands.

Fidelity Disruptive Medicine ETF Trading Up 1.6%

The company has a 50 day moving average price of $31.74 and a 200 day moving average price of $27.85. The company has a market capitalization of $51.90 million, a P/E ratio of 34.37 and a beta of 0.76.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

An institutional investor recently bought a new stake in Fidelity Disruptive Medicine ETF stock. Root Financial Partners LLC acquired a new position in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,291 shares of the company’s stock, valued at approximately $42,000. Root Financial Partners LLC owned 0.08% of Fidelity Disruptive Medicine ETF at the end of the most recent reporting period.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.